Month: June 2021

– Oral-only dosing for the Treatment of CABP Expands the Commercial Opportunity for Primary Care Promotion – Primary Care Market Opportunity for CABP Estimated at Approximately $1.5 Billion BOSTON, June 01, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and for other public health threats for civilian, government and military use, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for the oral-only dosing regimen of NUZYRA® for the treatment of adults with CABP. “The approval of an oral-only dose regimen for NUZYRA in pneumonia represents a significant opportunity...

BEVERLY, Mass., June 01, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it is taking steps to list its common shares on the Nasdaq Capital Market with the goal of submitting its application prior to the end of 2021. A successful listing on the Nasdaq will make the Company’s shares more accessible to retail and institutional investors in the United States and internationally as well as increase share liquidity. The Nasdaq is the Company’s preferred Exchange as it hosts the best biotech and life science companies in the world. LexaGene has taken several steps to prepare for a Nasdaq listing application. First, LexaGene has reserved with the Nasdaq Exchange the ticker...

MONTREAL, June 01, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes plasma atomized metal powders, environmentally friendly plasma waste-to-energy systems and clean plasma torch products, is pleased to announce today the appointments of Ms. Nannette Ramsey, as an independent director to the Board of Directors (the “Board”) and, separately, Mr. Ben Simo as Chief Financial Officer (CFO) of the Company. Ms. Ramsey holds undergraduate degrees in Economics, Engineering and an MBA. She brings manufacturing experience from Caterpillar Tractor Company, J.I. Case and more recently served as the Site Manager and Associate Director of Engineering...

MISSISSAUGA, Ontario, June 01, 2021 (GLOBE NEWSWIRE) — Smart Employee Benefits Inc., (“SEB”, TSXV:SEB), through its operating entities, has been awarded net new contracts valued in excess of $27.0M during the month of May, 2021. Clients included the Government of Canada and various corporate entities. The contracts extend out as long as 5 years. They include benefits processing contracts valued at over $2.0M and IT solutions and services valued at over $25.0M. This brings net new contract wins to in excess of $69.0M for fiscal 2021 year to date. The contracts are all net new business wins and add to SEB’s recurring revenue contract value. The majority are related to RFP (Request for Proposal) competitive bids. SEB’s RFP win rate in the past 6 months is >70%, an increase from >50% in fiscal 2020 and >30% in 2019. Our RFP win rate...

TORONTO and CHICAGO, June 01, 2021 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, today announced that Daniel Carcillo, CEO of Wesana, will participate in two upcoming events in June 2021:H.C. Wainwright’s Psychedelics in Psychiatry and Beyond Conference to be held virtually on Thursday, June 17, 2021. In addition to the Wesana corporate presentation, Mr. Carcillo will participate in the Disruptive Psychopharmacology – An Introduction to Psychedelics and the Coming Revolution in Psychiatry panel at 9:00 a.m. ET. To attend, please register here.Momentum’s...

K2 Sesame gold glacial train pointing up-ice at 2 km long Sesame Airborne IP (AIIP)Sesame AIIP anomaly (Airborne Interpreted Induced Polarization) up-ice of gold trainMONTREAL, June 01, 2021 (GLOBE NEWSWIRE) — Dios Exploration Inc. is very pleased to have uncovered a major 3 km long gold glacial train (B-horizon and boulders) targeting a significant source in a large volcanic hosted airborne IP on wholly-owned K2 property, west-southwest of Azimut’s Elmer gold property, James Bay Eeyou Istchee, QC.    The Sesame gold Target is a 2 km long by 200-400 m wide NE striking airborne IP anomaly, north of Kali pluton, 3.2 km up-ice of crumbly sericite enriched and carbonated felsic floats with 1-3% pyrite & quartz stringers that yielded up to 6.72 g/t Au, 29 g/t Ag, 0.2 %Cu, in perfect line up-ice of Wi-target goldbearing...

Figure 1 Makosa Tail location mapFigure 1 Makosa Tail location mapFigure 2 Makosa Tail drillhole location mapFigure 2 Makosa Tail drillhole location mapFigure 3 Makosa Tail Cross Section A-BFigure 3 Makosa Tail Cross Section A-BNOT FOR DISSEMINATION IN THE UNITED STATES OR FORDISTRIBUTION TO U.S. WIRE SERVICES VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) — Thor Explorations Ltd. (TSX VENTURE: THX) (“Thor” or the “Company”) is pleased to announce an encouraging first set of drill results from the southern Makosa Tail Prospect at its Douta Project, Senegal. The exploratory drilling program was designed to infill the initial wide-spaced drilling that was completed in late 2020 which led to the Makosa Tail discovery. The results received to date confirm the continuation...

WESTLAKE VILLAGE, Calif., June 01, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Rajvir (Raj) Madan has joined the company as its first Chief Digital and Information Officer. In this role, Mr. Madan will be responsible for providing the vision, strategic direction and overall leadership of digital, data/analytics and information technology initiatives across Arcutis. “We are thrilled to welcome Raj to our executive team. He brings deep expertise in digital and technology transformation in the healthcare sector, and under his guidance, Arcutis will look to evolve our digital and analytics capabilities...